Recently Published Articles on Vitiligo

Below you will find a list of recently published articles on vitiligo, subdivided into Review Articles, Clinical Articles, and Basic Science Articles. Each article is linked to its listing in PubMed. Please note that, due to copyright restrictions, the National Vitiligo Foundation can not provide a direct link to the full text or PDF version of the article.

To view articles from January through December 2009, please click here.

Review Articles

MAY 2010

Bowen C, Kobayashi TT. What is your diagnosis? Segmental vitiligo and en coup de sabre. Cutis. 2010 May;85(5):230, 237-8.

Ingordo V, Gentile C, Iannazzone S, Cusano F, Naldi L. Vitiligo and autoimmunity: an epidemiological study in a representative sample of young Italian males. J Eur Acad Dermatol Venereol. 2010 May 7.

Abu Tahir M, Pramod K, Ansari SH, Ali J. Current remedies for vitiligo. Autoimmun Rev. 2010 May;9(7):516-20.


APRIL 2010

Perossini M, Turio E, Perossini T, Cei G, Barachini P. Vitiligo: ocular and electrophysiological findings. G Ital Dermatol Venereol. 2010 Apr;145(2):141-9.

Cho SB, Kim JH, Cho S, Park JM, Park YK, Oh SH. Vitiligo in children and adolescents: association with thyroid dysfunction. J Eur Acad Dermatol Venereol. 2010 Apr 28.

Thompson AR, Clarke SA, Newell RJ, Gawkrodger DJ; The Appearance Research Collaboration (ARC). Vitiligo linked to stigmatization in British South Asian women: A qualitative study of the experiences of living with vitiligo. Br J Dermatol. 2010 Apr 26.


MARCH 2010

Tanioka M, Yamamoto Y, Kato M, Miyachi Y. Camouflage for patients with vitiligo vulgaris improved their quality of life. J Cosmet Dermatol. 2010 Mar;9(1):72-5.

Phd RC, Msc MP, Phd WP, Phd BZ, Msc TT, Febu TD. Transplantation of cultured autologous melanocytes - hope or danger? Cell Transplant. 2010 Mar 26.

Patel N, O'Haver J, Hansen RC. Vitiligo Therapy in Children: A Case for Considering Excimer Laser Treatment. Clin Pediatr (Phila). 2010 Mar 22.

Radtke MA, Schäfer I, Gajur AI, Augustin M. Clinical features and treatment outcomes of vitiligo from the patients' perspective: results of a national survey in Germany. Dermatology. 2010;220(3):194-200.

Albert DM. Melanoma, vitiligo, and uveitis. Ophthalmology. 2010 Mar;117(3):643-4.

Smith AG, Sturm RA. Multiple genes and locus interactions in susceptibility to vitiligo. J Invest Dermatol. 2010 Mar;130(3):643-5.


FEBRUARY 2010

Holla AP, Parsad D. Vitiligo surgery: its evolution as a definite treatment in the stable vitiligo. G Ital Dermatol Venereol. 2010 Feb;145(1):79-88.

Hossani-Madani AR, Halder RM. Topical treatment and combination approaches for vitiligo: new insights, new developments. G Ital Dermatol Venereol. 2010 Feb;145(1):57-78.

Akay BN, Bozkir M, Anadolu Y, Gullu S. Epidemiology of vitiligo, associated autoimmune diseases and audiological abnormalities: Ankara study of 80 patients in Turkey. J Eur Acad Dermatol Venereol. 2010 Feb 25.

Hossani-Madani AR, Halder RM. Topical treatment and combination approaches for vitiligo: new insights, new developments. G Ital Dermatol Venereol. 2010 Feb;145(1):57-78.

Abu Tahir M, Pramod K, Ansari SH, Ali J. Current remedies for vitiligo. Autoimmun Rev. 2010 Feb 8.


JANUARY 2010

Whitton ME, Pinart M, Batchelor J, Lushey C, Leonardi-Bee J, González U. Interventions for vitiligo. Cochrane Database Syst Rev. 2010 Jan 20;(1):CD003263.


Return to top of page

Clinical Articles

MAY 2010

Jung JY, Yeom KB, Eun HC. Chemical Leukoderma Improved by Low-dose Steroid Pulse Therapy. Ann Dermatol. 2010 May;22(2):241-4. Epub 2010 May 19.

Lee DY, Lee JH. White hairs in segmental vitiligo are related to poor response to phototherapy: demonstration with portable digital microscopy. J Dermatol. 2010 May;37(5):500-1.

Choi KW, Kim KH, Kim YH. Comparative Study of the Gross Interpretation of Phototesting and Objective Measurement with Using a Spectrophotometer for Patients with Psoriasis and Vitiligo Treated with Narrow-band UVB. Ann Dermatol. 2009 May;21(2):136-41.

de Leeuw J, Assen YJ, van der Beek N, Bjerring P, Martino Neumann HA. Treatment of vitiligo with khellin liposomes, ultraviolet light and blister roof transplantation. J Eur Acad Dermatol Venereol. 2010 May 7.

Majid I. Topical placental extract: does it increase the efficacy of narrowband UVB therapy in vitiligo? Indian J Dermatol Venereol Leprol. 2010 May-Jun;76(3):254-8.

Garg BJ, Saraswat A, Bhatia A, Katare OP. Topical treatment in vitiligo and the potential uses of new drug delivery systems. Indian J Dermatol Venereol Leprol. 2010 May-Jun;76(3):231-8.

Bahmani M, Fallahzadeh MK, Jowkar F, Khalesi M, Bahri-Najafi R, Namazi MR. Can topical phenytoin augment the therapeutic efficacy of PUVA against vitiligo? A double-blind, randomized, bilateral-comparison, placebo-controlled study. J Dermatolog Treat. 2010 May 5.

Köse O, Arca E, Kurumlu Z. Mometasone cream versus pimecrolimus cream for the treatment of childhood localized vitiligo. J Dermatolog Treat. 2010 May;21(3):133-9.

Wind BS, Kroon MW, Beek JF, van der Veen JP, Nieuweboer-Krobotová L, Meesters AA, Bos JD, Wolkerstorfer A. Home vs. outpatient narrowband ultraviolet B therapy for the treatment of nonsegmental vitiligo: a retrospective questionnaire study. Br J Dermatol. 2010 May;162(5):1142-4.


APRIL 2010

Al-Mutairi N, Manchanda Y, Al-Doukhi A, Al-Haddad A. Long-term results of split-skin grafting in combination with excimer laser for stable vitiligo. Dermatol Surg. 2010 Apr;36(4):499-505.

Lee DY, Lee JH. Epidermal grafting for vitiligo: a comparison of cultured and noncultured grafts. Clin Exp Dermatol. 2010 Apr;35(3):325-6.

Gamil H, Attwa E, Ghonemy S. Narrowband ultraviolet B as monotherapy and in combination with topical calcipotriol in the treatment of generalized vitiligo. Clin Exp Dermatol. 2010 Apr 26.

Lee DY, Lee KJ, Choi SC, Lee JH. Segmental vitiligo treated by the combination of epidermal grafting and systemic corticosteroids. Dermatol Surg. 2010 Apr;36(4):575-6.

Lee DY, Park JH, Lee JH, Yang JM, Lee ES. Surgical treatment is indicated in long-duration segmental vitiligo. Dermatol Surg. 2010 Apr;36(4):568-9.

Amerio P, Di Rollo D, Carbone A, Auriemma M, Marra ME, De Remigis P, Feliciani C, Tracanna M, Tulli A. Polyglandular autoimmune diseases in a dermatological clinical setting: vitiligo-associated autoimmune diseases. Eur J Dermatol. 2010 May-Jun;20(3):354-8. Epub 2010 Apr 16.

Khodadadi L, Shafieyan S, Sotoudeh M, Dizaj AV, Shahverdi A, Aghdami N, Baharvand H. Intraepidermal injection of dissociated epidermal cell suspension improves vitiligo. Arch Dermatol Res. 2010 Apr 4.

Murase JE, Koo JY, Berger TG. Narrowband ultraviolet B phototherapy influences serum folate levels in patients with vitiligo. J Am Acad Dermatol. 2010 Apr;62(4):710-1.


MARCH 2010

Yang YS, Cho HR, Ryou JH, Lee MH. Clinical study of repigmentation patterns with either narrow-band ultraviolet B (NBUVB) or 308 nm excimer laser treatment in Korean vitiligo patients. Int J Dermatol. 2010 Mar;49(3):317-23.

Di Nuzzo S, Masotti A. Depigmentation therapy in vitiligo universalis with cryotherapy and 4-hydroxyanisole. Clin Exp Dermatol. 2010 Mar;35(2):215-6.

Lee DY, Park JH, Lee JH, Yang JM, Lee ES. Recurrence of segmental vitiligo after epidermal grafting does not involve epidermal grafting area. Clin Exp Dermatol. 2010 Mar;35(2):205-6.

Le Duff F, Fontas E, Giacchero D, Sillard L, Lacour JP, Ortonne JP, Passeron T. 308-nm excimer lamp vs. 308-nm excimer laser for treating vitiligo: a randomized study. Br J Dermatol. 2010 Mar 23.

Seo I, Baqer A, Kollias N. The effect of visible light and near-infrared radiation on constitutive pigment of patients with vitiligo. Br J Dermatol. 2010 Mar 10.

Radtke MA, Schäfer I, Gajur AI, Augustin M. Clinical Features and Treatment Outcomes of Vitiligo from the Patients' Perspective: Results of a National Survey in Germany. Dermatology. 2010 Mar 5.

Wind BS, Kroon MW, Beek JF, van der Veen JP, Nieuweboer-Krobotová L, Meesters AA, Bos JD, Wolkerstorfer A. Home vs. outpatient narrowband ultraviolet B therapy for the treatment of nonsegmental vitiligo: a retrospective questionnaire study. Br J Dermatol. 2010 Mar 1.

Mchepange UO, Gao XH, Liu YY, Liu YB, Ma L, Zhang L, Chen HD. Vitiligo in North-Eastern China: An association between mucosal and acrofacial lesions. Acta Derm Venereol. 2010 Mar;90(2):136-40.


FEBRUARY 2010

Holla AP, Parsad D. Vitiligo surgery: its evolution as a definite treatment in the stable vitiligo. G Ital Dermatol Venereol. 2010 Feb;145(1):79-88.

Liu J, Man WY, Lv CZ, Song SP, Shi YJ, Elias PM, Man MQ. Epidermal Permeability Barrier Recovery Is Delayed in Vitiligo-Involved Sites. Skin Pharmacol Physiol. 2010 Feb 25;23(4):193-200.

Al-Mutairi N, Manchanda Y, Al-Doukhi A, Al-Haddad A. Long-Term Results of Split-Skin Grafting in Combination with Excimer Laser for Stable Vitiligo. Dermatol Surg. 2010 Feb 17.

Lo YH, Cheng GS, Huang CC, Chang WY, Wu CS. Efficacy and safety of topical tacrolimus for the treatment of face and neck vitiligo. J Dermatol. 2010 Feb;37(2):125-9.


JANUARY 2010

Tanioka M, Yamamoto Y, Katoh M, Takahashi K, Miyachi Y. Vitiligo vulgaris and autoimmune diseases in Japan: A report from vitiligo clinic in Kyoto University Hospital. Dermatoendocrinol. 2009 Jan;1(1):43-5.

Ali R, Ahsan MS, Azad MA, Ullah MA, Bari W, Islam SN, Yeasmin S, Hasnat A. Immunoglobulin levels of vitiligo patients. Pak J Pharm Sci. 2010 Jan;23(1):97-102.

Yan DM, Chang YX, Wang YF, Liu EW, Li J, Kang LY, Gao XM. In vivo pharmacokinetics of bakuchiol after oral administration of bakuchiol extraction in rat plasma. J Ethnopharmacol. 2010 Jan 5.


Return to top of page

Basic Science Articles

MAY 2010

Cho EA, Lee MA, Kang H, Lee SD, Kim HO, Park YM. Vitiligo-like Depigmentation Associated with Metastatic Melanoma of an Unknown Origin. Ann Dermatol. 2009 May;21(2):178-81.

Yun JY, Uhm YK, Kim HJ, Lim SH, Chung JH, Shin MK, Yim SV, Lee MH. Transforming growth factor beta receptor II (TGFBR2) polymorphisms and the association with nonsegmental vitiligo in the Korean population. Int J Immunogenet. 2010 May 27.

Song HJ, Choi GS, Shin JH. Preservation of melanoblasts of white hair follicles of segmental vitiligo lesions: A preliminary study. J Eur Acad Dermatol Venereol. 2010 May 17.

Jin Y, Birlea SA, Fain PR, Gowan K, Riccardi SL, Holland PJ, Mailloux CM, Sufit AJ, Hutton SM, Amadi-Myers A, Bennett DC, Wallace MR, McCormack WT, Kemp EH, Gawkrodger DJ, Weetman AP, Picardo M, Leone G, Taïeb A, Jouary T, Ezzedine K, van Geel N, Lambert J, Overbeck A, Spritz RA. Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo. N Engl J Med. 2010 May 6;362(18):1686-97. Epub 2010 Apr 21.


APRIL 2010

Kim NH, Lee AY. Reduced Aquaporin3 Expression and Survival of Keratinocytes in the Depigmented Epidermis of Vitiligo. J Invest Dermatol. 2010 Apr 29.

Deeba F, Syed R, Quareen J, Waheed M, Jamil K, Rao H. Ctla-4 a49g gene polymorphism is not associated with vitiligo in South Indian population. Indian J Dermatol. 2010;55(1):29-32.

Jalel A, Ridha A, Laurent D, Philippe M, Hamdaoui MH. Impact of hla-g in the outcome of vitiligo in tunisian patients. Indian J Dermatol. 2010;55(1):25-8.

Eskandani M, Golchai J, Pirooznia N, Hasannia S. Oxidative stress level and tyrosinase activity in vitiligo patients. Indian J Dermatol. 2010;55(1):15-9.

Philips MA, Kingo K, Karelson M, Rätsep R, Aunin E, Reimann E, Reemann P, Porosaar O, Vikeså J, Nielsen FC, Vasar E, Silm H, Kõks S. Promoter polymorphism -119C/G in MYG1 (C12orf10) gene is related to vitiligo susceptibility and Arg4Gln affects mitochondrial entrance of Myg1. BMC Med Genet. 2010 Apr 8;11:56.

Klarquist J, Denman CJ, Hernandez C, Wainwright DJ, Strickland FM, Overbeck A, Mehrotra S, Nishimura MI, Le Poole IC. Reduced skin homing by functional Treg in vitiligo. Pigment Cell Melanoma Res. 2010 Apr;23(2):276-86.


MARCH 2010

Agretti P, De Marco G, Sansone D, Betterle C, Coco G, Dimida A, Ferrarini E, Pinchera A, Vitti P, Tonacchera M. PATIENTS AFFECTED BY VITILIGO AND AUTOIMMUNE DISEASES DO NOT SHOW ANTIBODIES INTERFERING WITH THE ACTIVITY OF THE MELANOCORTIN 1 RECEPTOR. J Endocrinol Invest. 2010 Mar 22.

Manosroi J, Khositsuntiwong N, Manosroi W, Götz F, Werner RG, Manosroi A. Enhancement of transdermal absorption, gene expression and stability of tyrosinase plasmid (pMEL34)-loaded elastic cationic niosomes: Potential application in vitiligo treatment. J Pharm Sci. 2010 Mar 8;99(8):3533-3541.

Aroni K, Voudouris S, Ioannidis E, Grapsa A, Kavantzas N, Patsouris E. Increased angiogenesis and mast cells in the centre compared to the periphery of vitiligo lesions. Arch Dermatol Res. 2010 Mar 5.

Aslan S, Serarslan G, Teksoz E, Dagli S. Audiological and transient evoked otoacoustic emission findings in patients with vitiligo. Otolaryngol Head Neck Surg. 2010 Mar;142(3):409-14.

Xu S, Zhou Y, Yang S, Ren Y, Zhang C, Quan C, Gao M, He C, Chen H, Hhan J, Chen J, Liang Y, Yang J, Sun L, Yin X, Liu J, Zhang X. Platelet-derived growth factor receptor alpha gene mutations in vitiligo vulgaris. Acta Derm Venereol. 2010 Mar;90(2):131-5.


FEBRUARY 2010

de Castro CC, do Nascimento LM, Walker G, Werneck RI, Nogoceke E, Mira MT. Genetic Variants of the DDR1 Gene Are Associated with Vitiligo in Two Independent Brazilian Population Samples. J Invest Dermatol. 2010 Feb 25.

Xiang W, Xu A, Xu J, Bi Z, Shang Y, Ren Q. In vivo confocal laser scanning microscopy of hypopigmented macules: a preliminary comparison of confocal images in vitiligo, nevus depigmentosus and postinflammatory hypopigmentation. Lasers Med Sci. 2010 Feb 24.

Klarquist J, Denman CJ, Hernandez C, Wainwright DJ, Strickland FM, Overbeck A, Mehrotra S, Nishimura MI, Le Poole IC. REDUCED SKIN HOMING BY FUNCTIONAL TREG IN VITILIGO. Pigment Cell Melanoma Res. 2010 Feb 19.

Jeong TJ, Shin MK, Uhm YK, Kim HJ, Chung JH, Lee MH. Association of UVRAG polymorphisms with susceptibility to non-segmental vitiligo in a Korean sample. Exp Dermatol. 2010 Feb 16.

Yamanaka KI, Kakeda M, Kitagawa H, Tsuda K, Akeda T, Kurokawa I, Gabazza EC, Kupper TS, Mizutani H. 1,2,4-dihydroxyvitamin D (tacalcitol) prohibits skin T-cell infiltration. Br J Dermatol. 2010 Feb 15.

Gregg RK, Nichols L, Chen Y, Lu B, Engelhard VH. Mechanisms of spatial and temporal development of autoimmune vitiligo in tyrosinase-specific TCR transgenic mice. J Immunol. 2010 Feb 15;184(4):1909-17. Epub 2010 Jan 18.


JANUARY 2010

Becatti M, Prignano F, Fiorillo C, Pescitelli L, Nassi P, Lotti T, Taddei N. The involvement of Smac/DIABLO, p53, NF-kB and MAPK pathways in apoptosis of keratinocytes from perilesional vitiligo skin: protective effects of curcumin and capsaicin. Antioxid Redox Signal. 2010 Jan 19.

Gregg RK, Nichols L, Chen Y, Lu B, Engelhard VH. Mechanisms of Spatial and Temporal Development of Autoimmune Vitiligo in Tyrosinase-Specific TCR Transgenic Mice. J Immunol. 2010 Jan 18.

Kostyuk V, Potapovich A, Cesareo E, Brescia S, Guerra L, Valacchi G, Pecorelli A, Raskovic D, De Luca C, Pastore S, Korkina L. Dysfunction of Glutathione S-Transferase Leads to Excess 4-Hydroxy-2-Nonenal and H2O2 and Impaired Cytokine Pattern in Cultured Keratinocytes and Blood of Vitiligo Patients. Antioxid Redox Signal. 2010 Jan 13.

Ali R, Shamsul Ahsan M, Azad MA, Ashik Ullah M, Bari W, Nazrul Islam S, Yeasmin S, Hasnat A. Immunoglobulin levels of Vitiligo patients. Pak J Pharm Sci. 2010 Jan;23(4):97-102.

Dell'anna ML, Ottaviani M, Bellei B, Albanesi V, Cossarizza A, Rossi L, Picardo M. Membrane lipid defects are responsible for the generation of reactive oxygen species in peripheral blood mononuclear cells from vitiligo patients. J Cell Physiol. 2010 Jan 4;223(1):187-193.


Return to top of page